These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27742114)

  • 1. Shedding Light on the 2016 World Health Organization Classification of Tumors of the Central Nervous System in the Era of Radiomics and Radiogenomics.
    Colen RR; Hassan I; Elshafeey N; Zinn PO
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):741-749. PubMed ID: 27742114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of Central Nervous System Tumors Based on the 2016 World Health Organization Classification.
    Ly KI; Wen PY; Huang RY
    Neurol Clin; 2020 Feb; 38(1):95-113. PubMed ID: 31761063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2007 WHO classification of tumors of the central nervous system - what has changed?
    Rousseau A; Mokhtari K; Duyckaerts C
    Curr Opin Neurol; 2008 Dec; 21(6):720-7. PubMed ID: 18989119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. -New frontiers in domain-inspired radiomics and radiogenomics: increasing role of molecular diagnostics in CNS tumor classification and grading following WHO CNS-5 updates.
    Singh G; Singh A; Bae J; Manjila S; Spektor V; Prasanna P; Lignelli A
    Cancer Imaging; 2024 Oct; 24(1):133. PubMed ID: 39375809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
    Fuller CE; Jones DTW; Kieran MW
    Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates in the Neuoroimaging and WHO Classification of Primary CNS Gliomas: A Review of Current Terminology, Diagnosis, and Clinical Relevance From a Radiologic Prospective.
    Colip C; Oztek MA; Lo S; Yuh W; Fink J
    Top Magn Reson Imaging; 2019 Apr; 28(2):73-84. PubMed ID: 31022050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.
    Komori T
    Neurol Med Chir (Tokyo); 2017 Jul; 57(7):301-311. PubMed ID: 28592714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016.
    Malzkorn B; Reifenberger G
    Curr Opin Oncol; 2016 Nov; 28(6):494-501. PubMed ID: 27606698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building diagnoses with four layers: WHO 2016 classification of CNS tumors.
    Bielle F
    Rev Neurol (Paris); 2016; 172(4-5):253-5. PubMed ID: 27210026
    [No Abstract]   [Full Text] [Related]  

  • 10. World Health Organization 2016 Classification of Central Nervous System Tumors.
    Diamandis P; Aldape K
    Neurol Clin; 2018 Aug; 36(3):439-447. PubMed ID: 30072064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2016 WHO classification of central nervous system tumors: what neurologists need to know.
    DeWitt JC; Mock A; Louis DN
    Curr Opin Neurol; 2017 Dec; 30(6):643-649. PubMed ID: 28901970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
    Gritsch S; Batchelor TT; Gonzalez Castro LN
    Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Revised WHO Classification of Tumours of the Central Nervous System:Summary of the Revision and Perspective].
    Komori T; Sasaki H; Yoshida K
    No Shinkei Geka; 2016 Aug; 44(8):625-35. PubMed ID: 27506840
    [No Abstract]   [Full Text] [Related]  

  • 14. 2016 World Health Organization Classification of Central Nervous System Tumors.
    Wen PY; Huse JT
    Continuum (Minneap Minn); 2017 Dec; 23(6, Neuro-oncology):1531-1547. PubMed ID: 29200109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards an integrated morphological and molecular WHO diagnosis of central nervous system tumors: a paradigm shift.
    Rushing EJ; Wesseling P
    Curr Opin Neurol; 2015 Dec; 28(6):628-32. PubMed ID: 26402407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Genomics Into Neuro-Oncology Clinical Trials and Practice.
    Galanis E; Nassiri F; Coy S; Nejad R; Zadeh G; Santagata S
    Am Soc Clin Oncol Educ Book; 2018 May; 38():148-157. PubMed ID: 30231374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community.
    Aldape K; Nejad R; Louis DN; Zadeh G
    Neuro Oncol; 2017 Mar; 19(3):336-344. PubMed ID: 27688263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
    Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.
    Onizuka H; Masui K; Komori T
    Int J Clin Oncol; 2020 Jun; 25(6):997-1003. PubMed ID: 32468200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histologic classification of central nervous system tumors by the World Health Organization].
    Szymaś J
    Pol J Pathol; 1994; 45(2):81-91. PubMed ID: 8062070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.